Mounjaro®
Starting from £179.99/mo
Start journey Learn moreFor most people, Wegovy injections cause little more than brief, mild discomfort at the injection site — clinical trials reported injection-site reactions in a minority of participants, and the needle is fine enough that many describe the sensation as a small pinch. Pain, where it occurs, is usually short-lived. That said, semaglutide is a prescription-only medicine, and whether it suits you is a decision made with a prescriber after a proper clinical assessment — not something to judge from a forum thread alone.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The STEP 1 trial (the pivotal phase-3 study whose results were published in the New England Journal of Medicine) enrolled nearly 2,000 adults with obesity and tracked them for 68 weeks on semaglutide 2.4mg. Injection-site reactions were recorded in a small proportion of participants on the active drug. Crucially, none of those reactions was flagged as a reason most people stopped treatment; the discontinuation picture was dominated by gastrointestinal effects, not needle pain.
The pen itself is pre-filled and uses a concealed, very fine needle. Most patients describe the injection as a brief pinch, some notice nothing at all. Minor redness or a small raised bump at the site can appear and typically settles within an hour or two. If you want a fuller picture of what the pen looks and feels like, the Wegovy treatment page walks through the pen mechanism in plain language.
One thing worth knowing: the autoinjector does the hard work. You press it against the skin, press the button, and it's done in seconds. The pen that arrives is discreet (plain packaging, tracked delivery) so even opening the parcel is less of an event than people expect.
Ask anyone who has been on semaglutide for a few months and they'll almost always talk about nausea before they mention the needle. The NHS medicines information for semaglutide lists nausea, diarrhoea, vomiting, constipation, indigestion and stomach pain as the most common side effects, and clinical trial data back this up: gastrointestinal symptoms affected a meaningful share of participants, particularly in the first weeks after starting or after a dose step up.
This is worth framing correctly. Semaglutide slows the movement of food through your digestive system (that is part of how it reduces appetite) and the gut sometimes protests at first. The symptoms are typically most noticeable in the days after a new dose and often settle within one to two weeks as your body adjusts. For a closer look at how stomach-specific discomfort plays out, the Wegovy stomach pain guide goes into considerably more detail.
The licensed dose schedule builds slowly (starting at 0.25mg and stepping up over several months) precisely because a gradual approach reduces GI burden. Your prescriber decides the pace; the titration is never something to rush independently.
Beyond the injection site and the gut, a handful of other pain-adjacent experiences are reported by patients on semaglutide. Bloating and trapped wind are common enough to have their own dedicated discussion, gas pain on Wegovy is a recognised pattern and usually manageable with diet adjustments. Some people report leg discomfort, though this is not among the primary listed side effects and warrants a conversation with your prescriber if it's persistent. Skin sensitivity around the injection site is also occasionally noted; the skin pain page covers what's normal versus what needs attention. Back pain has been raised by some users too, the back pain and Wegovy page addresses the evidence, such as it is.
The general pattern across all these is that most discomfort is mild, tends to cluster in the early weeks of treatment or after dose increases, and resolves without medical intervention. When it doesn't (when pain is severe, persistent, or accompanied by symptoms like vomiting you can't keep fluids through) that's a signal to contact a clinician promptly. Severe, persistent stomach pain that spreads to the back, with or without vomiting, should always be assessed urgently given what is known about pancreatitis risk with GLP-1 medicines.
There are several straightforward steps that make injections more comfortable and reduce site reactions. Take the pen out of the fridge around 15 minutes before injecting so it reaches room temperature, cold solution stings more. Rotate your injection site each week: abdomen, outer thigh, upper arm are all suitable, and moving around prevents the repeated local inflammation that builds up when the same spot is used repeatedly. Letting the skin dry completely after cleaning, and keeping the pen pressed firmly but not forcefully against the skin during the injection, both help.
On the GI side, eating smaller, lower-fat meals and avoiding foods that already trigger bloating or indigestion tends to make the adjustment period easier. Staying well hydrated matters too, particularly if nausea reduces your appetite for fluids. These aren't substitutes for clinical guidance (your prescriber and the patient information leaflet are the right source for personal advice) but they reflect what patients most commonly find useful.
If you're weighing up semaglutide against other options, the semaglutide overview covers the broader evidence, and the weight-loss treatments page sets out the full range of approaches available. For anything that concerns you about your own experience on treatment, our support team is available seven days a week.
Wegovy is a prescription medicine. If you'd like a clinical assessment to find out whether it's right for you, start your free consultation and a GPhC-registered prescriber will review your answers the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.